Singhap, Renato T.
HRN: 25-33-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/21/2024
06/27/2024
IV
500 Mg
OD
Miliary TB
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes